1
15M
1
0.09
- Areas of investment
Summary
In 2010 was created Crystal Pharmatech, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Suzhou.
We can highlight the next thriving fund investment areas, such as Outsourcing, Pharmaceutical. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the various public portfolio startups of the fund, we may underline Laviana Pharma Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Crystal Pharmatech, startups are often financed by Lotus Lake Ventures, Agricultural Fund of China. The meaningful sponsors for the fund in investment in the same round are LYFE Capital, HY Capital, ABC Capital.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.09
- Investments by industry
- Pharmaceutical (1)
- Outsourcing (1)
- Biotechnology (1)
- Health Care (1)
- Investments by region
-
- China (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Laviana Pharma | 02 Jan 2018 | Biotechnology, Health Care, Pharmaceutical, Outsourcing | Early Stage Venture | 15M | China, Beijing, Dongcheng District |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.